{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:45:40Z","timestamp":1790880340405,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T00:00:00Z","timestamp":1720828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["48138"],"award-info":[{"award-number":["48138"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1ZIANS003129"],"award-info":[{"award-number":["1ZIANS003129"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.omtn.2024.102269","type":"journal-article","created":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T20:14:02Z","timestamp":1721160842000},"page":"102269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Allele-specific CRISPR-Cas9 editing inactivates a single nucleotide variant associated with collagen VI muscular dystrophy"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1690-9270","authenticated-orcid":false,"given":"V\u00e9ronique","family":"Bolduc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Sizov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Brull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace S.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prech","family":"Uapinyoying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apurva","family":"Sarathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kory R.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten G.","family":"B\u00f6nnemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2024.102269_bib1","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nrneurol.2011.81","article-title":"The collagen VI-related myopathies: muscle meets its matrix","volume":"7","author":"B\u00f6nnemann","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.omtn.2024.102269_bib2","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.matbio.2017.12.008","article-title":"Collagen VI disorders: Insights on form and function in the extracellular matrix and beyond","volume":"71\u201372","author":"Lamande","year":"2018","journal-title":"Matrix Biol."},{"key":"10.1016\/j.omtn.2024.102269_bib3","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/nen.0b013e3181634ef7","article-title":"Muscle\u00a0interstitial fibroblasts are the main source of collagen VI synthesis in skeletal muscle:\u00a0implications for congenital muscular dystrophy types Ullrich and Bethlem","volume":"67","author":"Zou","year":"2008","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.omtn.2024.102269_bib4","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1016\/j.yexcr.2008.08.006","article-title":"An enhancer required for transcription of the Col6a1 gene in muscle connective tissue is induced by signals released from muscle cells","volume":"314","author":"Braghetta","year":"2008","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.omtn.2024.102269_bib5","doi-asserted-by":"crossref","first-page":"18601","DOI":"10.1016\/S0021-9258(18)37327-7","article-title":"Amino acid sequence of the triple-helical domain of human collagen type VI","volume":"263","author":"Chu","year":"1988","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2024.102269_bib6","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1042\/bj2110303","article-title":"Electron-microscopical approach to a structural model of intima collagen","volume":"211","author":"Furthmayr","year":"1983","journal-title":"Biochem. J."},{"key":"10.1016\/j.omtn.2024.102269_bib7","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1083\/jcb.102.3.703","article-title":"Molecular assembly, secretion, and matrix deposition of type VI collagen","volume":"102","author":"Engvall","year":"1986","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.omtn.2024.102269_bib8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/2044-5040-1-30","article-title":"ColVI myopathies: where do we stand, where do we go?","volume":"1","author":"Allamand","year":"2011","journal-title":"Skeletal Muscle"},{"key":"10.1016\/j.omtn.2024.102269_bib9","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/ana.21439","article-title":"Collagen VI glycine mutations: perturbed assembly and a spectrum of clinical severity","volume":"64","author":"Pace","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtn.2024.102269_bib10","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1002\/humu.22429","article-title":"Position of Glycine Substitutions in the Triple Helix of COL6A1, COL6A2, and COL6A3 is Correlated with Severity and Mode of Inheritance in Collagen VI Myopathies","volume":"34","author":"Butterfield","year":"2013","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omtn.2024.102269_bib11","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1074\/jbc.M109932200","article-title":"Kinked collagen VI tetramers and reduced microfibril formation as a result of Bethlem myopathy and introduced triple helical glycine mutations","volume":"277","author":"Lamand\u00e9","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2024.102269_bib12","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.matbio.2018.06.005","article-title":"Extracellular matrix-driven congenital muscular dystrophies","volume":"71\u201372","author":"Mohassel","year":"2018","journal-title":"Matrix Biol."},{"key":"10.1016\/j.omtn.2024.102269_bib13","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ana.22283","article-title":"Large genomic deletions: a novel cause of Ullrich congenital muscular dystrophy","volume":"69","author":"Foley","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtn.2024.102269_bib14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1056\/NEJMra1705346","article-title":"Treating Disease at the RNA Level with Oligonucleotides","volume":"380","author":"Levin","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtn.2024.102269_bib15","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1089\/hum.2012.109","article-title":"Antisense-induced messenger depletion corrects a COL6A2 dominant mutation in Ullrich myopathy","volume":"23","author":"Gualandi","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2024.102269_bib16","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1038\/mtna.2014.22","article-title":"Allele-specific Gene Silencing of Mutant mRNA Restores Cellular Function in Ullrich Congenital Muscular Dystrophy Fibroblasts","volume":"3","author":"Noguchi","year":"2014","journal-title":"Nucleic Acids"},{"key":"10.1016\/j.omtn.2024.102269_bib17","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1038\/mtna.2013.74","article-title":"siRNA-mediated Allele-specific Silencing of a COL6A3 Mutation in a Cellular Model of Dominant Ullrich Muscular Dystrophy","volume":"3","author":"Bolduc","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2024.102269_bib18","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.omtn.2017.07.006","article-title":"Gapmer Antisense Oligonucleotides Suppress the Mutant Allele of COL6A3 and Restore Functional Protein in Ullrich Muscular Dystrophy","volume":"8","author":"Marrosu","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2024.102269_bib19","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.7150\/thno.43298","article-title":"Allele-specific genome targeting in the development of precision medicine","volume":"10","author":"Wu","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.omtn.2024.102269_bib20","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.omtn.2024.102269_bib21","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nrm.2017.48","article-title":"Non-homologous DNA end joining and alternative pathways to double-strand break repair","volume":"18","author":"Chang","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.omtn.2024.102269_bib22","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.tig.2021.02.008","article-title":"DNA Repair Pathway Choices in CRISPR-Cas9-Mediated Genome Editing","volume":"37","author":"Xue","year":"2021","journal-title":"Trends Genet."},{"key":"10.1016\/j.omtn.2024.102269_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-16279-4","article-title":"Towards personalised allele-specific CRISPR gene editing to treat autosomal dominant disorders","volume":"7","author":"Christie","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2024.102269_bib24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/crispr.2017.0009","article-title":"Allele-Specific CRISPR-Cas9 Genome Editing of the Single-Base P23H Mutation for Rhodopsin-Associated Dominant Retinitis Pigmentosa","volume":"1","author":"Li","year":"2018","journal-title":"CRISPR J."},{"key":"10.1016\/j.omtn.2024.102269_bib25","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.omtn.2018.03.007","article-title":"CRISPR\/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer's Disease. Molecular therapy","volume":"11","author":"Gyorgy","year":"2018","journal-title":"Nucleic Acids"},{"key":"10.1016\/j.omtn.2024.102269_bib26","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/s41591-019-0500-9","article-title":"Allele-specific gene editing prevents deafness in a model of dominant progressive hearing loss","volume":"25","author":"Gy\u00f6rgy","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2024.102269_bib27","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.omtn.2019.02.019","article-title":"Allele-Specific CRISPR\/Cas9 Correction of\u00a0a\u00a0Heterozygous DNM2 Mutation Rescues Centronuclear Myopathy Cell Phenotypes","volume":"16","author":"Rabai","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2024.102269_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.723023","article-title":"Allele-Specific Gene Editing Rescues Pathology in a Human Model of Charcot-Marie-Tooth Disease Type 2E","volume":"9","author":"Feliciano","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.omtn.2024.102269_bib29","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.141042","article-title":"Allele-specific silencing of the gain-of-function mutation in Huntington's disease using CRISPR\/Cas9","volume":"7","author":"Shin","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.omtn.2024.102269_bib30","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.nmd.2006.07.015","article-title":"A comparative analysis of collagen VI production in muscle, skin and fibroblasts from 14\u00a0Ullrich congenital muscular dystrophy patients with dominant and recessive COL6A mutations","volume":"16","author":"Jimenez-Mallebrera","year":"2006","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtn.2024.102269_bib31","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0945-053X(01)00160-3","article-title":"Collagen VI deficiency affects the organization of fibronectin in the extracellular matrix of cultured fibroblasts","volume":"20","author":"Sabatelli","year":"2001","journal-title":"Matrix Biol."},{"key":"10.1016\/j.omtn.2024.102269_bib32","article-title":"Optimized allele-specific silencing of the dominant-negative COL6A1 G293R substitution causing collagen VI-related dystrophy","volume":"35","author":"Brull","year":"2024","journal-title":"Nucleic Acids"},{"key":"10.1016\/j.omtn.2024.102269_bib33","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41586-018-0686-x","article-title":"Predictable and precise template-free CRISPR editing of pathogenic variants","volume":"563","author":"Shen","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2024.102269_bib34","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nbt.4317","article-title":"Predicting the mutations generated by repair of Cas9-induced double-strand breaks","volume":"37","author":"Allen","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2024.102269_bib35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ymthe.2016.11.010","article-title":"CRISPR\/Cas9 Editing of the Mutant Huntingtin Allele In\u00a0Vitro and In\u00a0Vivo","volume":"25","author":"Monteys","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2024.102269_bib36","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1089\/crispr.2021.0132","article-title":"Allele-Specific Inactivation of an Autosomal Dominant Epidermolysis Bullosa Simplex Mutation Using CRISPR-Cas9","volume":"5","author":"Bchetnia","year":"2022","journal-title":"CRISPR J."},{"key":"10.1016\/j.omtn.2024.102269_bib37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13059-019-1783-3","article-title":"AlleleAnalyzer: a tool for personalized and allele-specific sgRNA design","volume":"20","author":"Keough","year":"2019","journal-title":"Genome Biol."},{"key":"10.1016\/j.omtn.2024.102269_bib38","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.ymthe.2020.11.009","article-title":"Single-Base Resolution: Increasing the Specificity of the CRISPR-Cas System in Gene Editing","volume":"29","author":"Rabinowitz","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2024.102269_bib39","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nbt.2647","article-title":"DNA targeting specificity of RNA-guided Cas9 nucleases","volume":"31","author":"Hsu","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2024.102269_bib40","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nbt.2808","article-title":"Improving CRISPR-Cas nuclease specificity using truncated guide RNAs","volume":"32","author":"Fu","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2024.102269_bib41","article-title":"Profiling single-guide RNA specificity reveals a mismatch sensitive core sequence","volume":"7","author":"Zheng","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2024.102269_bib42","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature16526","article-title":"High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects","volume":"529","author":"Kleinstiver","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2024.102269_bib43","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.aad5227","article-title":"Rationally engineered Cas9 nucleases with improved specificity","volume":"351","author":"Slaymaker","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.omtn.2024.102269_bib44","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s42003-019-0627-8","article-title":"High-fidelity endonuclease variant HypaCas9 facilitates accurate allele-specific gene modification in mouse zygotes","volume":"2","author":"Ikeda","year":"2019","journal-title":"Commun. Biol."},{"key":"10.1016\/j.omtn.2024.102269_bib45","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1038\/s41467-019-11454-9","article-title":"Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing","volume":"10","author":"Maule","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2024.102269_bib46","article-title":"A highly specific CRISPR-Cas12j nuclease enables allele-specific genome editing","volume":"9","author":"Wang","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtn.2024.102269_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084410","article-title":"CRISPR\/Cas9-Mediated Allele-Specific Disruption of a Dominant COL6A1 Pathogenic Variant Improves Collagen VI Network in Patient Fibroblasts","volume":"23","author":"L\u00f3pez-M\u00e1rquez","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2024.102269_bib48","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/humu.22691","article-title":"Mosaicism for dominant collagen 6 mutations as a cause for intrafamilial phenotypic variability","volume":"36","author":"Donkervoort","year":"2015","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omtn.2024.102269_bib49","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.ejpn.2017.07.009","article-title":"Somatic mosaicism represents an underestimated event underlying collagen 6-related disorders","volume":"21","author":"D'Amico","year":"2017","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.omtn.2024.102269_bib50","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 Gene Editing for Sickle Cell Disease and beta-Thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtn.2024.102269_bib51","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa2107454","article-title":"CRISPR-Cas9 In\u00a0Vivo Gene Editing for Transthyretin Amyloidosis","volume":"385","author":"Gillmore","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtn.2024.102269_bib52","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.ymthe.2020.05.002","article-title":"Mutation-Independent Allele-Specific Editing by CRISPR-Cas9, a Novel Approach to Treat Autosomal Dominant Disease","volume":"28","author":"Christie","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2024.102269_bib53","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nbt.3437","article-title":"Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9","volume":"34","author":"Doench","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2024.102269_bib54","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.1038\/s41467-018-07901-8","article-title":"Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities","volume":"9","author":"Sanson","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2024.102269_bib55","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omtn.2024.102269_bib56","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","article-title":"CRISPResso2 provides accurate and rapid genome editing sequence analysis","volume":"37","author":"Clement","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2024.102269_bib57","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124403","article-title":"A recurrent COL6A1 pseudoexon insertion causes muscular dystrophy and is effectively targeted by splice-correction therapies","volume":"4","author":"Bolduc","year":"2019","journal-title":"JCI Insight"}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253124001562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253124001562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T23:00:31Z","timestamp":1728514831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253124001562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2162253124001562"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2024.102269","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.03.22.586265","asserted-by":"object"}]},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allele-specific CRISPR-Cas9 editing inactivates a single nucleotide variant associated with collagen VI muscular dystrophy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2024.102269","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102269"}}